Cost Of Revenue - Bausch Health Companies Inc (NYSE:BHC) - Alpha Spread
B

Bausch Health Companies Inc
NYSE:BHC

Watchlist Manager
Bausch Health Companies Inc
NYSE:BHC
Watchlist
Price: 8.32 USD 0.6% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch Health Companies Inc
Cost of Revenue Peer Comparison

Comparables:
SNDL
C
CRON
C
CURA
T
TER

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bausch Health Companies Inc
NYSE:BHC
Cost of Revenue
-$2.7B
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
Sundial Growers Inc
NASDAQ:SNDL
Cost of Revenue
-CA$689.3m
CAGR 3-Years
-137%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cronos Group Inc
NASDAQ:CRON
Cost of Revenue
-$85.1m
CAGR 3-Years
2%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Cost of Revenue
-$1.3B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Cost of Revenue
-$146.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bausch Health Companies Inc's Cost of Revenue?
Cost of Revenue
-2.7B USD

Based on the financial report for Jun 30, 2024, Bausch Health Companies Inc's Cost of Revenue amounts to -2.7B USD.

What is Bausch Health Companies Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-1%

Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Bausch Health Companies Inc have been -4% over the past three years , -3% over the past five years , and -1% over the past ten years .

Back to Top